Clinical Trial Update: the Cardioprotective Effects of Improving Potassium Variability in Maintenance Hemodialysis Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating whether improving potassium variability provides cardioprotection in patients undergoing maintenance hemodialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease On Hemodialysis
• Hyperkalemia
• Hypokalemia
• Myocardial Injury

Snippet

Sponsor: Qianfoshan Hospital | Conditions: Chronic Kidney Disease on Hemodialysis, Hypokalemia | Phase 4 | Status: NOT_YET_RECRUITING